| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3996594 | Practical Radiation Oncology | 2015 | 9 Pages |
Abstract
Definitive dose radiation therapy may improve survival in a select subset of patients with minimal extrathoracic disease in whom local progression is of primary concern. Prospective trials are needed to further evaluate the role of local control in oligometastatic NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eric P. MD, JD, Elizabeth PhD, Charles B. MD, Surbhi MD, MPH, Annemarie T. MD, Sonam MD, Michael N. MD, PhD, Tracey L. MD, Corey J. MD, Nandita PhD, Anand MD, MPH, Smith MD, Lilie L. MD, Ramesh MD, PhD,